Next Article in Journal
A Survey of Attitude on Sperm Banking and Barriers to Its Use among Testicular Cancer Patients in a Multicultural Asian Population
Previous Article in Journal
2022 WUOF/SIU International Consultation on Urological Diseases: Management of Toxicity and Side Effects of Systemic Therapy for Renal Cell Carcinoma
 
 
Société Internationale d’Urologie Journal is published by MDPI from Volume 5 Issue 1 (2024). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Société Internationale d’Urologie.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Interesting Images

Renal Cell Carcinoma with Intratumoral Pseudoaneurysm

by
Daniel P. Pierce
1,*,
Elias H. Salloum
2 and
Philippe E. Spiess
2
1
University of South Florida Department of Urology, Tampa, FL 33606, USA
2
Moffitt Cancer Center, Tampa, FL 33612, USA
*
Author to whom correspondence should be addressed.
Soc. Int. Urol. J. 2022, 3(6), 501-502; https://doi.org/10.48083/RHXJ2561
Submission received: 21 May 2022 / Revised: 21 May 2022 / Accepted: 24 May 2022 / Published: 16 November 2022
Pseudoaneurysms can be present both pre- and postoperatively, occurring as frequently as 23% of the time by postoperative day seven. This specific case was found secondary to a standard preoperative evaluation and workup in a patient with otherwise undisturbed surgical fields suggesting de novo formation within the renal tumor. Factors considered for preoperative intervention included size of overall tumor, size of pseudoaneurysm, complex surgical anatomy of renal vasculature, and baseline risk of major intraoperative or postoperative hemorrhage. Renal artery embolization was performed using multiple detachable Concerto microcoils, resulting in complete occlusion. The following day via a subcostal incision the left upper pole and main renal arteries and vein were controlled, allowing for safe removal of the left kidney and adrenal gland with minimal measured blood loss at 300 mL and an uneventful postoperative course.

Competing Interests

None declared. Patient consent: obtained.
Figure 1.  
Figure 1.  
Siuj 03 00501 g001
Figure 2.  
Figure 2.  
Siuj 03 00501 g002
Figure 3.  
Figure 3.  
Siuj 03 00501 g003
Figure 4.  
Figure 4.  
Siuj 03 00501 g004

Share and Cite

MDPI and ACS Style

Pierce, D.P.; Salloum, E.H.; Spiess, P.E. Renal Cell Carcinoma with Intratumoral Pseudoaneurysm. Soc. Int. Urol. J. 2022, 3, 501-502. https://doi.org/10.48083/RHXJ2561

AMA Style

Pierce DP, Salloum EH, Spiess PE. Renal Cell Carcinoma with Intratumoral Pseudoaneurysm. Société Internationale d’Urologie Journal. 2022; 3(6):501-502. https://doi.org/10.48083/RHXJ2561

Chicago/Turabian Style

Pierce, Daniel P., Elias H. Salloum, and Philippe E. Spiess. 2022. "Renal Cell Carcinoma with Intratumoral Pseudoaneurysm" Société Internationale d’Urologie Journal 3, no. 6: 501-502. https://doi.org/10.48083/RHXJ2561

APA Style

Pierce, D. P., Salloum, E. H., & Spiess, P. E. (2022). Renal Cell Carcinoma with Intratumoral Pseudoaneurysm. Société Internationale d’Urologie Journal, 3(6), 501-502. https://doi.org/10.48083/RHXJ2561

Article Metrics

Back to TopTop